Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Plus Therapeutics (PSTV) Preferred Dividend Payments (2017 - 2019)

Plus Therapeutics (PSTV) has disclosed Preferred Dividend Payments for 5 consecutive years, with $554000.0 as the latest value for Q3 2019.

  • On a quarterly basis, Preferred Dividend Payments fell 77.72% to $554000.0 in Q3 2019 year-over-year; TTM through Dec 2019 was $3.0 million, a 52.95% decrease, with the full-year FY2019 number at $554000.0, down 77.72% from a year prior.
  • Preferred Dividend Payments was $554000.0 for Q3 2019 at Plus Therapeutics, down from $2.5 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $4.0 million in Q4 2017 to a low of $554000.0 in Q3 2019.
  • A 4-year average of $1.9 million and a median of $1.6 million in 2015 define the central range for Preferred Dividend Payments.
  • Biggest YoY gain for Preferred Dividend Payments was 77.72% in 2019; the steepest drop was 77.72% in 2019.
  • Plus Therapeutics' Preferred Dividend Payments stood at $661000.0 in 2015, then surged by 501.66% to $4.0 million in 2017, then crashed by 37.47% to $2.5 million in 2018, then crashed by 77.72% to $554000.0 in 2019.
  • Per Business Quant, the three most recent readings for PSTV's Preferred Dividend Payments are $554000.0 (Q3 2019), $2.5 million (Q3 2018), and $4.0 million (Q4 2017).